JANX   $50.24  0.52% Market Closed After Close 50.2 -0.08%

Janux Therapeutics Inc
Total Cash 646.29M
totalCashPerShare 12.39
EBITDA -63.86M
Total Debt 23.82M
quickRatio 57.025
currentRatio 57.336
Total Revenue 15.13M
debtToEquity 3.622
Revenue/Share 0.309
ROA -0.07979
ROE -0.09203
grossProfits
freeCashflow -36.22M
operatingCashflow -46.47M
earningsGrowth
revenueGrowth 7.417
grossMargins -2.51035
ebitdaMargins 0.0
operatingMargins -1.55356
profitMargins -2.91168
enterpriseValue 1.99B
forwardPE -30.369566
floatShares 28.87M
sharesOutstanding 52.16M
sharesShort 3.32M
sharesShortPriorMonth 3.66M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.09%
heldPercentInstitutions 1.00%
Short Ratio help_outline 6.61%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 12.608
Price To Book help_outline 3.88
earningsQuarterlyGrowth
netIncomeToCommon -44.05M
trailingEps -0.88%
forwardEps -1.61%
enterpriseToEbitda -31.10
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 3Q 2024
institutionsCount 216
lastUpdated Sept. 16, 2024, 8:24 p.m.